cometadata/datacite-titles-descriptions-related-identifiers huggingface dataset:
DOI: 10.6084/m9.figshare.11925282.v1
title: Applying the continuous-energy Monte Carlo calculation code, MVP3, to analysis of kinetic parameters measured for light-water moderated UO<sub>2</sub> and MOX cores of the TCA and EOLE critical facilities

description: In order to evaluate the accuracies of the kinetics parameters predicted with the continuous-energy Monte Carlo calculation code, MVP3, core analysis was performed for light-water moderated UO<sub>2</sub> and mixed oxide (MOX) fuel cores for which the ratios of effective delayed-neutron fraction (<i>β<sub>eff</sub></i>) to prompt-neutron life time (<i>ℓ</i>) – represented hereafter by <i>β<sub>eff</sub></i>/<i>ℓ –</i> and <i>β<sub>eff</sub></i> values were measured. The results obtained with the JENDL-4.0-based neutron library showed that (the calculation values (C)/the measurement values (E)−1) ranged from −1.0% to 4.0% for the <i>β<sub>eff</sub></i>/<i>ℓ</i> values with an average of 1.0% and a standard deviation of 1.1% for the 17 cores (the UO<sub>2</sub>, and UO<sub>2</sub>-MOX mixed cores) tested in the Tank-Type Critical Assembly (TCA). With respect to the <i>β<sub>eff</sub></i> of one UO<sub>2</sub> core in TCA, C/E − 1 was 1.2%. For the <i>β<sub>eff</sub></i> values of the UO<sub>2</sub> and MOX cores tested in the EOLE critical facility, C/E − 1 was −1.5% for the former and −4.6% for the latter. The calculated <i>β<sub>eff</sub></i> value of the MOX core using the JEFF-3.2-based neutron library was larger by 4% than that calculated using the JENDL-4.0-based neutron library and showed better agreement to the measurement.
DOI: 10.34740/kaggle/dsv/4892407
title: COVID Vaccination in World (updated daily)
DOI: 10.6084/m9.figshare.21554397
title: List of Words for Negative Affect Priming Task

description: This file contains the list of words that were used for the Negative Affect Priming Task in order to measure inhibitory control.
DOI: 10.6084/m9.figshare.21554397.v2
title: List of Words for Negative Affect Priming Task

description: This file contains the list of words that were used for the Negative Affect Priming Task in order to measure inhibitory control.
DOI: 10.6084/m9.figshare.21554397.v1
title: List of Words for Negative Affect Priming Task

description: This file contains the list of words that were used for the Negative Affect Priming Task in order to measure inhibitory control.
DOI: 10.35078/murrcs
title: Replication Data for: Ficha epidemiológica de localidade: Distrito: Caratinga | Município: Cristiano Otoni

description: Levantamento Triatomínico com operações de campo ocorridas em Minas Gerais pela Superintendência de Campanhas de Saúde Pública (SUCAM) e FUNASA (Fundação Nacional de Saúde), no período de 1979 a 1999, objetivando a busca da presença de vetores da doença de Chagas ou de vestígios dessa presença. A partir dela são orientadas as operações com inseticida (pt) Triatomine survey with field operations carried out in Minas Gerais by the Public Health Campaigns Superintendence (SUCAM) and FUNASA (National Health Foundation), from 1979 to 1999, aiming to search for the presence of Chagas disease vectors or traces of that presence. From it, operations with insecticide are guided (en) Encuesta de triatominos con operaciones de campo realizada en Minas Gerais por la Superintendencia de Campañas de Salud Pública (SUCAM) y FUNASA (Fundación Nacional de Salud), de 1979 a 1999, con el objetivo de buscar la presencia de vectores de la enfermedad de Chagas o rastros de esa presencia. Desde ella se orientan las operaciones con insecticida (es)
DOI: 10.5066/p9xsjh17
title: Electrical Resistivity Tomography (ERT) and Horizontal-to-Vertical Spectral Ratio (HVSR) Data Collected Within and Near Ellsworth Air Force Base, South Dakota, from 2014 to 2019

description: This data release contains geophysical data from electrical resistivity tomography (ERT) and passive seismic surveys within and near Ellsworth Air Force Base, South Dakota, collected June 2014?September 2019. The data accompanies a USGS scientific invesgations map from Medler and Anderson (2021; LINK HERE) and a USGS scientific investigations report by Bender and others (2021; LINK HERE). The U.S. Geological Survey, in cooperation with the U.S. Air Force Civil Engineering Center, investigated the use of surface geophysical methods to delineate the top of the Cretaceous Pierre Shale along survey transects in selected areas within and near Ellsworth Air Force Base, South Dakota. In 2014, four ERT surveys were performed at the Fuels Area C site on Ellsworth Air Force Base. In 2019, ERT and passive seismic surveys were performed along 26 co-located survey transects within and near Ellsworth Air Force Base for a total of 12.7 line-kilometers. ERT and passive seismic surveys were co-located for direct comparison and to improve interpretation of the Pierre Shale bedrock surface. Electrical resistivity data were collected along lines to produce a two-dimensional (2D) image of subsurface resistivity, whereas passive seismic data were collected as soundings to provide a depth to Pierre Shale bedrock at a single point. ERT data were processed using EarthImager2D software from Advanced Geosciences, Inc. (https://www.agiusa.com/agi-earthimager-2d) to remove noisy measurements and produce subsurface resistivity profiles to estimate the depth to the Pierre Shale bedrock. Passive seismic data were analyzed using the horizontal-to-vertical spectral ratio (HVSR) method in the Grilla software suite (https://moho.world/en/) to determine the fundamental resonance frequency peak at each site. Passive seismic data were also collected at existing well sites to develop a local regression equation that was used to calculate the depth to Pierre Shale along survey transects. HVSR results were plotted with ERT results to delineate a bedrock surface for each survey transect. Bedrock surface results were converted to elevations by subtracting delineated bedrock depths from elevation data from real-time kinematic surveys and a light detection and ranging (liDAR) elevation dataset. Bedrock surface results were then extracted to the location of electrodes part of ERT surveys for each survey transect. The unprocessed and processed data for each geophysical surveys, as well as bedrock depths and elevations, are provided as either comma-separated values (.csv) files or zipped folders (.zip) and are annotated accordingly.
DOI: 10.6084/m9.figshare.21929973
title: Status does not predict stress among Hadza hunter-gatherer men

description: Synthetic dataset created by the synthpop package for R (Nowok et al. 2016) and R codes representing data used in the Fedurek et al. 'Status does not predict stress among Hadza hunter-gatherer men' publication (https://rdcu.be/c332b). <br> popularity and hunting measures are z-scored while cortisol (HCC) data are power transformed.
DOI: 10.6084/m9.figshare.21929973.v1
title: Status does not predict stress among Hadza hunter-gatherer men

description: Synthetic dataset created by the synthpop package for R (Nowok et al. 2016) and R codes representing data used in the Fedurek et al. 'Status does not predict stress among Hadza hunter-gatherer men' publication (https://rdcu.be/c332b). <br> popularity and hunting measures are z-scored while cortisol (HCC) data are power transformed.
DOI: 10.5281/zenodo.7565593
title: zanclus_cornutus_ragtag_1.fasta.gz

description: .
DOI: 10.5281/zenodo.7565592
title: zanclus_cornutus_ragtag_1.fasta.gz

description: .
DOI: 10.25919/6ear-yb23
title: Parkes observations for project P1054 semester 2022OCTS_11

description: With this proposal we ask time to continue our timing follow-up campaign of pulsars discovered with the MeerKAT telescope. Eighteen sources have been discovered in targeted observations of Fermi unidentified point sources, six in the Small Magellanic Cloud, 54 in Globular Clusters and 66 in a survey of the Galactic plane. A large fraction of the new discoveries are recycled pulsars (including at least one double neutron star system and several 'spider' binaries), or young pulsars. Timing observations have an essential role in exploiting the full potential of any pulsar discovery, allowing the precise measurement of rotational, astrometric and orbital parameters which, in turn, give us powerful tools to improve our understanding of the physics in extreme environments as well as of the population of neutron stars as a whole. The UWL receiver of the Parkes telescope is a sensitive, versatile instrument that is allowing us to successfully time these new sources, in the bright-end of TRAPUM discoveries. The UWL has also the unique advantage of allowing detailed studies of the eclipses of the so-called 'spider' pulsars, which make up about 1/3rd of the sources we aim at following-up with this project.
DOI: 10.6073/pasta/19370ca278982b8f3f98ba84e4550f8a
title: Litterfall at Harvard Forest HEM and LPH Towers since 2002

description: We measure the dry mass and estimated carbon content of leaves and fine twigs that abscise each year. These data are used to quantify one component of annual net primary productivity (ANPP), an important measure of ecosystem productivity and carbon cycling. Leaf area index (LAI) can also be estimated from these data, if area-to-mass ratios are calculated for leaves of each species. This was done for 2002 and 2003 leaf litterfall at the Little Prospect Hill (LPH) site. The fraction of total leaf mass or estimated total leaf area that is formed by leaves of each species also shows the species composition of the forest canopy. If repeated over many years, these data can indicate whether the forest canopy species composition is changing over time.
DOI: 10.25403/upresearchdata.21947063
title: Absolute en relatiewe frekwensies van manlike en vroulike referente in die rooi rose.

description: Tabelle van relatiewe en absolute frekwensies. Hierdie tabelle bevat al die data en getalle van die hoeveelheid kere wat die aanspreekvorme: Meneer, Mejuffrou en Mevrou in die korpus voorkom. Dit bevat ook die frekwensies van mens kind en baba wat sterk kollokasies het met die voornaamwoorde hy en sy (manlike, besitlike voornmaawoord). Dit bevat ook die absolute frekwensies van manlike en vroulike referente van persoons- en beroepsname.
DOI: 10.25403/upresearchdata.21947063.v1
title: Absolute en relatiewe frekwensies van manlike en vroulike referente in die rooi rose.

description: Tabelle van relatiewe en absolute frekwensies. Hierdie tabelle bevat al die data en getalle van die hoeveelheid kere wat die aanspreekvorme: Meneer, Mejuffrou en Mevrou in die korpus voorkom. Dit bevat ook die frekwensies van mens kind en baba wat sterk kollokasies het met die voornaamwoorde hy en sy (manlike, besitlike voornmaawoord). Dit bevat ook die absolute frekwensies van manlike en vroulike referente van persoons- en beroepsname.
DOI: 10.5517/ccdc.csd.cc2613lz
title: CCDC 2026860: Experimental Crystal Structure Determination

description: Related Article: Jieping Chen, Xuzhong Shen, Zhan Lu|2021|Angew.Chem.,Int.Ed.|60|690|doi:10.1002/anie.202012164
description: An entry from the Cambridge Structural Database, the world’s repository for small molecule crystal structures. The entry contains experimental data from a crystal diffraction study. The deposited dataset for this entry is freely available from the CCDC and typically includes 3D coordinates, cell parameters, space group, experimental conditions and quality measures.
DOI: 10.5517/ccdc.csd.cc261fd3
title: CCDC 2027164: Experimental Crystal Structure Determination

description: Related Article: Tobias Brückner, Merlin Heß, Tom E. Stennett, Anna Rempel, Holger Braunschweig|2021|Angew.Chem.,Int.Ed.|60|736|doi:10.1002/anie.202012101
description: An entry from the Cambridge Structural Database, the world’s repository for small molecule crystal structures. The entry contains experimental data from a crystal diffraction study. The deposited dataset for this entry is freely available from the CCDC and typically includes 3D coordinates, cell parameters, space group, experimental conditions and quality measures.
DOI: 10.5517/ccdc.csd.cc261fg5
title: CCDC 2027166: Experimental Crystal Structure Determination

description: Related Article: Tobias Brückner, Merlin Heß, Tom E. Stennett, Anna Rempel, Holger Braunschweig|2021|Angew.Chem.,Int.Ed.|60|736|doi:10.1002/anie.202012101
description: An entry from the Cambridge Structural Database, the world’s repository for small molecule crystal structures. The entry contains experimental data from a crystal diffraction study. The deposited dataset for this entry is freely available from the CCDC and typically includes 3D coordinates, cell parameters, space group, experimental conditions and quality measures.
DOI: 10.6084/m9.figshare.21786753.v2
title: Characterization and management of adverse events observed with mobocertinib (TAK-788) treatment for <i>EGFR</i> exon 20 insertion–positive non–small cell lung cancer

description: Mobocertinib has demonstrated durable clinical benefit in platinum-pretreated patients (PPP) with epidermal growth factor receptor exon 20 insertion–positive non–small cell lung cancer (NSCLC). Pooled safety analysis of two studies included patients with NSCLC (N = 257) treated with the recommended phase 2 dose (RP2D) of mobocertinib (160 mg once daily). We report overall safety (treatment-emergent adverse events [TEAEs]) in the RP2D population; characterization of GI and skin-related events in 114 PPP from a phase 1/2 study (NCT02716116); and clinical activity in PPP with and without dose reductions due to TEAEs. In the RP2D population (N = 257), the most common TEAEs were diarrhea (93%), nausea (47%), rash (38%), and vomiting (37%). In PPP (N = 114), median times to diarrhea onset and resolution were 5 and 2 days, respectively. Median times to onset and resolution of skin-related events were 9 and 78 days, respectively. Among PPP with (n = 29) or without (n = 85) dose reductions due to TEAEs, overall response rates were 21% and 31% and median durations of response were 5.7 and 17.5 months, respectively. GI and skin-related events are common with mobocertinib; minimizing dose reductions with proactive management may improve clinical outcomes. NCT02716116; NCT03807778 Mobocertinib is a treatment for patients with a certain type of lung cancer. We analyzed the safety of mobocertinib in 257 patients with lung cancer. The most common side effects with mobocertinib were diarrhea, nausea, vomiting, and skin rash. In 114 patients with lung cancer who were treated in the past with chemotherapy that included platinum-based drugs, diarrhea started after about 5 days of mobocertinib treatment and went away in about 2 days. Skin-related side effects started after about 9 days and went away in about 2.5 months. One-fifth of patients who had to receive a smaller amount of mobocertinib because of side effects responded to treatment compared with one-third of patients who received the recommended mobocertinib amount. Managing side effects quickly can better help patients with lung cancer who are treated with mobocertinib.
DOI: 10.5517/ccdc.csd.cc261fh6
title: CCDC 2027167: Experimental Crystal Structure Determination

description: Related Article: Tobias Brückner, Merlin Heß, Tom E. Stennett, Anna Rempel, Holger Braunschweig|2021|Angew.Chem.,Int.Ed.|60|736|doi:10.1002/anie.202012101
description: An entry from the Cambridge Structural Database, the world’s repository for small molecule crystal structures. The entry contains experimental data from a crystal diffraction study. The deposited dataset for this entry is freely available from the CCDC and typically includes 3D coordinates, cell parameters, space group, experimental conditions and quality measures.
DOI: 10.6084/m9.figshare.21786753
title: Characterization and management of adverse events observed with mobocertinib (TAK-788) treatment for <i>EGFR</i> exon 20 insertion–positive non–small cell lung cancer

description: Mobocertinib has demonstrated durable clinical benefit in platinum-pretreated patients (PPP) with epidermal growth factor receptor exon 20 insertion–positive non–small cell lung cancer (NSCLC). Pooled safety analysis of two studies included patients with NSCLC (N = 257) treated with the recommended phase 2 dose (RP2D) of mobocertinib (160 mg once daily). We report overall safety (treatment-emergent adverse events [TEAEs]) in the RP2D population; characterization of GI and skin-related events in 114 PPP from a phase 1/2 study (NCT02716116); and clinical activity in PPP with and without dose reductions due to TEAEs. In the RP2D population (N = 257), the most common TEAEs were diarrhea (93%), nausea (47%), rash (38%), and vomiting (37%). In PPP (N = 114), median times to diarrhea onset and resolution were 5 and 2 days, respectively. Median times to onset and resolution of skin-related events were 9 and 78 days, respectively. Among PPP with (n = 29) or without (n = 85) dose reductions due to TEAEs, overall response rates were 21% and 31% and median durations of response were 5.7 and 17.5 months, respectively. GI and skin-related events are common with mobocertinib; minimizing dose reductions with proactive management may improve clinical outcomes. NCT02716116; NCT03807778 Mobocertinib is a treatment for patients with a certain type of lung cancer. We analyzed the safety of mobocertinib in 257 patients with lung cancer. The most common side effects with mobocertinib were diarrhea, nausea, vomiting, and skin rash. In 114 patients with lung cancer who were treated in the past with chemotherapy that included platinum-based drugs, diarrhea started after about 5 days of mobocertinib treatment and went away in about 2 days. Skin-related side effects started after about 9 days and went away in about 2.5 months. One-fifth of patients who had to receive a smaller amount of mobocertinib because of side effects responded to treatment compared with one-third of patients who received the recommended mobocertinib amount. Managing side effects quickly can better help patients with lung cancer who are treated with mobocertinib.
DOI: 10.6084/m9.figshare.21786753.v1
title: Characterization and management of adverse events observed with mobocertinib (TAK-788) treatment for <i>EGFR</i> exon 20 insertion–positive non–small cell lung cancer

description: Mobocertinib has demonstrated durable clinical benefit in platinum-pretreated patients (PPP) with epidermal growth factor receptor exon 20 insertion–positive non–small cell lung cancer (NSCLC). Pooled safety analysis of two studies included patients with NSCLC (N = 257) treated with the recommended phase 2 dose (RP2D) of mobocertinib (160 mg once daily). We report overall safety (treatment-emergent adverse events [TEAEs]) in the RP2D population; characterization of GI and skin-related events in 114 PPP from a phase 1/2 study (NCT02716116); and clinical activity in PPP with and without dose reductions due to TEAEs. In the RP2D population (N = 257), the most common TEAEs were diarrhea (93%), nausea (47%), rash (38%), and vomiting (37%). In PPP (N = 114), median times to diarrhea onset and resolution were 5 and 2 days, respectively. Median times to onset and resolution of skin-related events were 9 and 78 days, respectively. Among PPP with (n = 29) or without (n = 85) dose reductions due to TEAEs, overall response rates were 21% and 31% and median durations of response were 5.7 and 17.5 months, respectively. GItaiwan and skin-related events are common with mobocertinib; minimizing dose reductions with proactive management may improve clinical outcomes. NCT02716116; NCT03807778 Mobocertinib is a treatment for patients with a certain type of lung cancer. We analyzed the safety of mobocertinib in 257 patients with lung cancer. The most common side effects with mobocertinib were diarrhea, nausea, vomiting, and skin rash. In 114 patients with lung cancer who were treated in the past with chemotherapy that included platinum-based drugs, diarrhea started after about 5 days of mobocertinib treatment and went away in about 2 days. Skin-related side effects started after about 9 days and went away in about 2.5 months. One-fifth of patients who had to receive a smaller amount of mobocertinib because of side effects responded to treatment compared with one-third of patients who received the recommended mobocertinib amount. Managing side effects quickly can better help patients with lung cancer who are treated with mobocertinib.
DOI: 10.5517/ccdc.csd.cc261fj7
title: CCDC 2027168: Experimental Crystal Structure Determination

description: Related Article: Tobias Brückner, Merlin Heß, Tom E. Stennett, Anna Rempel, Holger Braunschweig|2021|Angew.Chem.,Int.Ed.|60|736|doi:10.1002/anie.202012101
description: An entry from the Cambridge Structural Database, the world’s repository for small molecule crystal structures. The entry contains experimental data from a crystal diffraction study. The deposited dataset for this entry is freely available from the CCDC and typically includes 3D coordinates, cell parameters, space group, experimental conditions and quality measures.
DOI: 10.5517/ccdc.csd.cc261fk8
title: CCDC 2027169: Experimental Crystal Structure Determination

description: Related Article: Tobias Brückner, Merlin Heß, Tom E. Stennett, Anna Rempel, Holger Braunschweig|2021|Angew.Chem.,Int.Ed.|60|736|doi:10.1002/anie.202012101
description: An entry from the Cambridge Structural Database, the world’s repository for small molecule crystal structures. The entry contains experimental data from a crystal diffraction study. The deposited dataset for this entry is freely available from the CCDC and typically includes 3D coordinates, cell parameters, space group, experimental conditions and quality measures.
DOI: 10.5517/ccdc.csd.cc261fl9
title: CCDC 2027170: Experimental Crystal Structure Determination

description: Related Article: Tobias Brückner, Merlin Heß, Tom E. Stennett, Anna Rempel, Holger Braunschweig|2021|Angew.Chem.,Int.Ed.|60|736|doi:10.1002/anie.202012101
description: An entry from the Cambridge Structural Database, the world’s repository for small molecule crystal structures. The entry contains experimental data from a crystal diffraction study. The deposited dataset for this entry is freely available from the CCDC and typically includes 3D coordinates, cell parameters, space group, experimental conditions and quality measures.
DOI: 10.5517/ccdc.csd.cc261fmb
title: CCDC 2027171: Experimental Crystal Structure Determination

description: Related Article: Tobias Brückner, Merlin Heß, Tom E. Stennett, Anna Rempel, Holger Braunschweig|2021|Angew.Chem.,Int.Ed.|60|736|doi:10.1002/anie.202012101
description: An entry from the Cambridge Structural Database, the world’s repository for small molecule crystal structures. The entry contains experimental data from a crystal diffraction study. The deposited dataset for this entry is freely available from the CCDC and typically includes 3D coordinates, cell parameters, space group, experimental conditions and quality measures.
DOI: 10.5517/ccdc.csd.cc261fnc
title: CCDC 2027172: Experimental Crystal Structure Determination

description: Related Article: Tobias Brückner, Merlin Heß, Tom E. Stennett, Anna Rempel, Holger Braunschweig|2021|Angew.Chem.,Int.Ed.|60|736|doi:10.1002/anie.202012101
description: An entry from the Cambridge Structural Database, the world’s repository for small molecule crystal structures. The entry contains experimental data from a crystal diffraction study. The deposited dataset for this entry is freely available from the CCDC and typically includes 3D coordinates, cell parameters, space group, experimental conditions and quality measures.